Long COVID and the Autonomic Nervous System: The Journey from Dysautonomia to Therapeutic Neuro-Modulation through the Retrospective Analysis of 152 Patients.

IF 1.6 Q3 CLINICAL NEUROLOGY NeuroSci Pub Date : 2022-05-23 eCollection Date: 2022-06-01 DOI:10.3390/neurosci3020021
Joseph Colombo, Michael I Weintraub, Ramona Munoz, Ashish Verma, Ghufran Ahmad, Karolina Kaczmarski, Luis Santos, Nicholas L DePace
{"title":"Long COVID and the Autonomic Nervous System: The Journey from Dysautonomia to Therapeutic Neuro-Modulation through the Retrospective Analysis of 152 Patients.","authors":"Joseph Colombo, Michael I Weintraub, Ramona Munoz, Ashish Verma, Ghufran Ahmad, Karolina Kaczmarski, Luis Santos, Nicholas L DePace","doi":"10.3390/neurosci3020021","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The severity and prevalence of Post-Acute COVID-19 Sequela (PACS) or long-COVID syndrome (long COVID) should not be a surprise. Long-COVID symptoms may be explained by oxidative stress and parasympathetic and sympathetic (P&S) dysfunction. This is a retrospective, hypothesis generating, outcomes study.</p><p><strong>Methods: </strong>From two suburban practices in northeastern United States, 152 long COVID patients were exposed to the following practices: (1) first, they were P&S tested (P&S Monitor 4.0; Physio PS, Inc., Atlanta, GA, USA) prior to being infected with COVID-19 due to other causes of autonomic dysfunction; (2) received a pre-COVID-19 follow-up P&S test after autonomic therapy; (3) then, they were infected with COVID-19; (4) P&S tested within three months of surviving the COVID-19 infection with long-COVID symptoms; and, finally, (5) post-COVID-19, follow-up P&S tested, again, after autonomic therapy. All the patients completed autonomic questionnaires with each test. This cohort included 88 females (57.8%), with an average age of 47.0 years (ranging from 14 to 79 years), and an average BMI of 26.9 #/in<sup>2</sup>.</p><p><strong>Results: </strong>More pre-COVID-19 patients presented with sympathetic withdrawal than parasympathetic excess. Post-COVID-19, these patients presented with this ratio reversed and, on average, 49.9% more autonomic symptoms than they did pre-COVID-19.</p><p><strong>Discussion: </strong>Both parasympathetic excess and sympathetic withdrawal are separate and treatable autonomic dysfunctions and autonomic treatment significantly reduces the prevalence of autonomic symptoms.</p><p><strong>Conclusion: </strong>SARS-CoV-2, via its oxidative stress, can lead to P&S dysfunction, which, in turn, affects the control and coordination of all systems throughout the whole body and may explain all of the symptoms of long-COVID syndrome. Autonomic therapy leads to positive outcomes and patient quality of life may be restored.</p>","PeriodicalId":74294,"journal":{"name":"NeuroSci","volume":"3 2","pages":"300-310"},"PeriodicalIF":1.6000,"publicationDate":"2022-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11523758/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NeuroSci","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/neurosci3020021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The severity and prevalence of Post-Acute COVID-19 Sequela (PACS) or long-COVID syndrome (long COVID) should not be a surprise. Long-COVID symptoms may be explained by oxidative stress and parasympathetic and sympathetic (P&S) dysfunction. This is a retrospective, hypothesis generating, outcomes study.

Methods: From two suburban practices in northeastern United States, 152 long COVID patients were exposed to the following practices: (1) first, they were P&S tested (P&S Monitor 4.0; Physio PS, Inc., Atlanta, GA, USA) prior to being infected with COVID-19 due to other causes of autonomic dysfunction; (2) received a pre-COVID-19 follow-up P&S test after autonomic therapy; (3) then, they were infected with COVID-19; (4) P&S tested within three months of surviving the COVID-19 infection with long-COVID symptoms; and, finally, (5) post-COVID-19, follow-up P&S tested, again, after autonomic therapy. All the patients completed autonomic questionnaires with each test. This cohort included 88 females (57.8%), with an average age of 47.0 years (ranging from 14 to 79 years), and an average BMI of 26.9 #/in2.

Results: More pre-COVID-19 patients presented with sympathetic withdrawal than parasympathetic excess. Post-COVID-19, these patients presented with this ratio reversed and, on average, 49.9% more autonomic symptoms than they did pre-COVID-19.

Discussion: Both parasympathetic excess and sympathetic withdrawal are separate and treatable autonomic dysfunctions and autonomic treatment significantly reduces the prevalence of autonomic symptoms.

Conclusion: SARS-CoV-2, via its oxidative stress, can lead to P&S dysfunction, which, in turn, affects the control and coordination of all systems throughout the whole body and may explain all of the symptoms of long-COVID syndrome. Autonomic therapy leads to positive outcomes and patient quality of life may be restored.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
长COVID与自主神经系统:通过对 152 名患者的回顾性分析,了解从自主神经失调症到治疗性神经调节的历程。
导言:急性 COVID-19 后遗症(PACS)或长 COVID 综合征(long COVID)的严重性和普遍性不足为奇。氧化应激和副交感神经及交感神经(P&S)功能障碍可解释长 COVID 症状。这是一项回顾性、假设性、结果性研究:美国东北部两个郊区诊所的 152 名长期 COVID 患者接受了以下治疗:(1)首先,对他们进行 P&S 测试(P&S Monitor 4.0; Physio PS, Inc、美国佐治亚州亚特兰大市));(2) 在接受自主神经治疗后,接受 COVID-19 前的后续 P&S 测试;(3) 然后,感染 COVID-19;(4) 在感染 COVID-19 后三个月内接受 P&S 测试,并伴有长期 COVID 症状;最后,(5) COVID-19 后,在接受自主神经治疗后,再次接受后续 P&S 测试。所有患者在每次测试时都填写了自主神经问卷。结果显示,88 名女性患者(57.8%)的平均年龄为 47.0 岁(14 至 79 岁不等),平均体重指数为 26.9 #/in2:结果:COVID-19 前交感神经功能减退的患者多于副交感神经功能过剩的患者。COVID-19之后,这些患者的这一比例发生了逆转,自律神经症状平均比COVID-19前多49.9%:讨论:副交感神经功能亢进和交感神经功能减退都是独立的、可治疗的自律神经功能紊乱,自律神经治疗可显著降低自律神经症状的发生率:结论:SARS-CoV-2通过其氧化应激作用可导致P&S功能障碍,进而影响全身所有系统的控制和协调,并可解释长期COVID综合征的所有症状。自律神经疗法可带来积极的疗效,患者的生活质量也可得到恢复。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
11 weeks
期刊最新文献
Exploring Neuroprotection against Radiation-Induced Brain Injury: A Review of Key Compounds. Resting-State Functional Connectivity Predicts Attention Problems in Children: Evidence from the ABCD Study. Trehalose: Neuroprotective Effects and Mechanisms-An Updated Review. Discontinuation of Cerebro-Spinal Fluid (CSF) Drainage in Acute Hydrocephalus: A Prospective Cohort Study and Exploratory Data Analysis. Wearable EEG-Based Brain-Computer Interface for Stress Monitoring.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1